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Abstract
Objective
Moyamoya disease (MMD) is a chronic, occlusive, cerebrovascular disorder of 
unknown pathogenesis, characterized by progressive stenosis of the bilateral 
supraclinoid internal carotid arteries, with concomitant formation of tortuous 
arterial collateral vessels at the base of the brain, which reconstitute distal 
branches of the cerebral circulation. In Japanese, “Moyamoya” means “hazy 
puff of smoke” and refers to the angiographic appearance of the abnormal 
network of vessels that develop at the base of the brain and basal ganglia to 
supply a collateral route of blood flow.
We report here the case of Moyamoya disease in a 5 year-old girl with normal 
mentality with a one year history of epilepsy, with Todd’s paralysis. This 
condition is rare and most patients are diagnosed in childhood. With this report 
we aim to underscore the possibility that a usual neurological sign could be 
associated with unusual neurological disorders.
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Introduction
Moyamoya disease(MMD) was initially described by Suzuki and Takaku in 1963 
as a radiographic phenomenon relating to tiny collateral vessels, characteristic of 
the disease that resemble a cloud or puff of smoke; it consists of occlusive vascular 
disease at the  events and small strokes. (1, 2) This disease is an idiopathic chronic 
progressive arterial occlusive disease that affects the distal intra cranial carotid 
arteries and the vessels arising from the circle of Willis (3). Secondary causes of 
distal intracranial artery occlusion such as atherosclerosis, vasculitis, and cardiogenic 
embolus may cause a similar syndrome (moyamoya syndrome). This syndrome 
also has been associated with neurofibromatosis, sickle cell disease, meningitis, and 
cranial radiation (4). The disease typically presents with cerebral ischemic symptoms 
in children and brain hemorrhage in adults (5), and can manifest as hemiparesies, 
monoparesis, sensory impairment, involuntary movement, headaches, dizziness, 
or seizures. Mental retardation or persistent neurology defects may be present (6). 
Etiology of the disease is unknown, and the condition is observed mainly in infants, 
children and adolescents, and seemingly more in females than in males (7,8). The 
prevalence of the disease is 0.86 per 100,000 in the United States and about 0.35- 
3.5 cases per 100,000 in Japan. There is strong evidence of hereditary factors in 
the disease, with familial cases reported especially among the Japanese, but also 
Europe and in identical twins (8, 9). Pathologically, MMD is characterized by 
intimal thickening in the walls of the terminal portions on internal carotid vessels 
58 Iran J Child Neurology  Jan  2009
bilaterally. The proliferating intima may contain lipid 
deposits (10,11). On clinical examination, children may 
have hemiparesies, monoparesis, sensory impairment, 
involuntary movement, headaches, dizziness, or seizures; 
mental retardation or persistent neurology defects may 
be present (6).
Cerebral angiography is the standard criterion for 
diagnosis, and the following findings support the 
diagnosis: 
1- Stenosis or occlusion at the terminal portion of the 
internal carotid artery or the proximal portion of 
the anterior or middle cerebral arteries.
2- Abnormal vascular networks in the vicinity of the 
occlusive or stenotic areas.
3- Bilaterally  of the described findings. 
Magnetic resonance angiography (MRA) may preclude 
the need for conventional angiography (12, 13).
Treatment is directed primarily at complications of 
the disease. If intracranial hemorrhage has occurred, 
management of hypertension (if present) is imperative. 
In case of severe stroke, ICU monitoring is indicated until 
the patient’s condition stabilizes and if the patient has 
had an ischemic stroke, anticoagulation or an antiplatelet 
agent should be considered (14).
Various surgical procedures have been used for these 
patients; those who present for treatment while symptoms 
are evolving have a better prognosis than 
those who present with static symptoms (which probably 
indicate a stroke). Procedures used include:




5- Omental transplantation (15, 16).
The prognosis of the disease is not good and mortality 
rates are approximately 10% in adults and 4.3% in 
children. Death is usually from hemorrhage, and about 
50-60% of affected individuals experience a gradual 
deterioration of cognitive function, presumably from 
recurrent strokes. 
Case Report 
A five year-old girl was admitted in our hospital with a 
chief complaint of seizures. The patient was the second 
child of unrelated Iranian parents, with history of seizures 
since she was 15 months old after her DPT vaccination. 
She was delivered at term by normal vaginal delivery 
with a birth weight of 3000 gr; her mentality was normal. 
In her 4th year of life she experienced seizures with 
Todd’s paralysis, and was treated with Carbamazepine. 
When the paralysis duration became prolonged, she was 
brought to the clinic following her last episode of seizure 
with paraplegia. Physical examination showed the cranial 
nerve was intact, without loss of consciousness, deep 
tendon reflexes were increased;Plantar reflex and was 
downward , and muscle forces were reduced; sensory 
and motor exams were normal, and the cerebellum was 
unremarkable.
Laboratory data included: WBC count of 7500 cell/mm3, 
PMNs 35%, lymphocytes 55%, Hb 12.5gr/dl, Hct 38% 
and platelets 35 x 10 9/l. ESR 15 mm/hr, CRP(-), Ca 9.1 
mg/dl, BS 80 mg/dl, Na 136 meq/l and K 4.1 meq/l.
The patient underwent a CT scan for primary evaluation, 
which showed cortical opacity in the bilateral frontal lobe 
parenchyma; an MRI imaging showed ischemic changes 
(small vessels disease) in the periventricular region and 
lacunars infarction in both brain hemispheres. With this 
evidence, suspicions of vascular anomaly increased and 
the patient underwent MRA/MRI and CT angiography 
(figures 1&2), which confirmed the diagnosis of 
moyamoya disease.
Discussion 
In this case the diagnosis was based on past medical 
history of seizure, clinical features of stroke (paraplegia) 
& imaging findings. MMD should be considered in any 
patient with acute symptoms of stroke. This disease 
usually shows various neurologic signs. In children, 
the disease occurs in early childhood, around the age 
of 5 years. The neurological manifestations could be 
varied, ranging from Transient Ischemic Attack (TIA) 
to extensive bilateral strokes, seizures, involuntary 
movements and speech disturbances. Some children 
may have mental retardation due to long-term ischemia 
or repeated infarctions. Much data is available on MMD 
in current literature, in particular the related neurologic 
problems. This patient presented with clinical features of 
seizures, signals of bilateral upper motor neuron lesion 
and paraplegia.
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Figure 1: CT angiography of patient showing multiple collaterals of left carotid artery that resemble Moyamoya disease. 
Figure 2: The puff of smoke view, characteristic of Moyamoya disease.
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